An objective method for the pre-operative diagnosis and the post-operative assessment of a presumed perilymphatic fistula (PLF) using transtympanic electrocochleography is presented. Three cases are reported in which the history of the disease and the symptoms strongly suggested the presence of a PLF. Pre-operative transtympanic electrocochleography (TT ECoG) recordings at rest showed changes similar to those of endolymphatic hydrops and signs of instability of the inner ear hydrodynamic system during raised intrathoracic pressure. Surgery revealed a visible leak in two of the three cases. Both windows were repaired in all the patients. All patients were relieved from their vestibular symptoms at the time when the post-operative TT ECoG was conducted 3-6 months later. The post-operative recordings were stable during raised intrathoracic pressure and the previously elevated summating potentials decreased which was interpreted as an objective indication of the recovery of the hydrodynamic system. However, later one of the patients again developed recurrent vertigo. Twenty patients with well-documented Ménière’s disease were used as a control group. TT ECoG was conducted during raised intrathoracic pressure. The Ménière patients showed stable recordings. It is suggested that among patients with suspected PLF and signs of hydrops in TT ECoG, a dependence on the intrathoracic pressure reflected in the recordings may indicate a possible fistula.

Keywords:
Electrocochleography, Perilymphatic fistula, Intrathoracic pressure, Vertigo
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.